MEG3 and metabolic dysfunction-associated steatotic liver disease: The hidden molecular mechanism could be that lncRNA-MEG3 competitively binds to miR-21 with LRP6 to suppress the mTOR pathway and stimulate lipid accumulation in cells, resulting in NAFLD.